Nick Screaton
- Pulmonary and Respiratory Medicine top 10%
- Cardiology and Cardiovascular Medicine
- Immunology
- Genetics
- Epidemiology
- Co-authors
- David P. JenkinsMichael M. MadaniEckhard MayerThida WinJoanna C. PorterJudith BabarTryphon LambrouAshley M. Groves
- Topics
- Pulmonary Hypertension Research and Treatments (5 papers)Vascular Anomalies and Treatments (4 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers)
- Partner nations
- United KingdomJapanSpain
In The Last Decade
Nick Screaton
13 papers receiving 274 citations
Peers
Comparison fields: 5 of 32
- Pulmonary and Respiratory Medicine 252
- Cardiology and Cardiovascular Medicine 115
- Immunology 41
- Genetics 40
- Epidemiology 39
Countries citing papers authored by Nick Screaton
This map shows the geographic impact of Nick Screaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Screaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Screaton more than expected).
Fields of papers citing papers by Nick Screaton
This network shows the impact of papers produced by Nick Screaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Screaton. The network helps show where Nick Screaton may publish in the future.
Co-authorship network of co-authors of Nick Screaton
This figure shows the co-authorship network connecting the top 25 collaborators of Nick Screaton. A scholar is included among the top collaborators of Nick Screaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Screaton. Nick Screaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 12 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | The broad clinical spectrum and unexpected features of Activated PI3-kinase Delta Syndrome; large patient cohort study | 0 |
| 7 | 39 | |
| 8 | 24 | |
| 9 | 5 | |
| 10 | 45 | |
| 11 | 89 | |
| 12 | The importance of correction for tissue fraction effects in lung PET | 1 |
| 13 | 50 | |
| 14 | 1 |
About Nick Screaton
Nick Screaton is a scholar working on Internal Medicine, Genetics and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 280 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (5 papers), Vascular Anomalies and Treatments (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). The work is most often cited by research in Internal Medicine (33 citations), Pulmonary and Respiratory Medicine (252 citations) and Cardiology and Cardiovascular Medicine (115 citations). Nick Screaton has collaborated with scholars based in United Kingdom, Japan and Spain. Frequent co-authors include David P. Jenkins, Michael M. Madani, Eckhard Mayer, Thida Win, Joanna C. Porter, Judith Babar, Tryphon Lambrou, Ashley M. Groves, Anita Chandra and Andrew Exley. Their work appears in journals such as Thorax, European Journal of Nuclear Medicine and Molecular Imaging and European Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.